LDLR and triple-A syndrome: To further test the potential of a local endovascular delivery of lenvatinib to halt aneurysm growth, we established a large animal model with inducible AAA in hypercholesterolemic LDL receptor–knockout (LDLR–/–) Yucatan minipigs (Supplemental Figure 11, A and B).